A Randomized Exploratory Trial of an Alpha-7 Nicotinic Receptor Agonist (TC-5619) for Cognitive Enhancement in Schizophrenia

por Lieberman, Jeffrey A, Dunbar, Geoffrey, Segreti, Anthony C, Girgis, Ragy R, Seoane, Frances, Beaver, Jessica S, Duan, Naihua, Hosford, David A
Publicado 2013

Two novel alleles of tottering with distinct Ca(v)2.1 calcium channel neuropathologies

por Miki, Takafumi, Zwingman, Theresa A., Wakamori, Minoru, Lutz, Cathy M., Cook, Susan A., Hosford, David A., Herrup, Karl, Fletcher, Colin F., Mori, Yasuo, Frankel, Wayne N., Letts, Verity A.
Publicado 2008

Phase 2 Trial of an Alpha-7 Nicotinic Receptor Agonist (TC-5619) in Negative and Cognitive Symptoms of Schizophrenia

por Walling, David, Marder, Stephen R., Kane, John, Fleischhacker, W. Wolfgang, Keefe, Richard S. E., Hosford, David A., Dvergsten, Chris, Segreti, Anthony C., Beaver, Jessica S., Toler, Steven M., Jett, John E., Dunbar, Geoffrey C.
Publicado en Schizophr Bull (2016)